Nokea
Myxoedema coma is characterized by:
- A. Hypertension
- B. Tachycardia
- C. Euthermia
- D. Hypoventilation
Correct Answer: B
Rationale: Myxoedema coma is a severe form of hypothyroidism that can lead to the slowing down of various body functions, including reduced heart rate (bradycardia). As the condition progresses and the body's metabolism becomes more depressed, one of the compensatory mechanisms is an increase in heart rate (tachycardia) to try to maintain adequate tissue perfusion. Therefore, tachycardia is a characteristic feature of myxoedema coma, rather than hypertension or euthermia which are not typically associated with this condition. Hypoventilation is also a common feature of myxoedema coma due to the decreased metabolic rate and respiratory drive.
You may also like to solve these questions
All the following drugs are associated with an increased risk of osteoporosis in adults except:
- A. Cyclosporine
- B. Heparin
- C. Prednisone
- D. Ranitidine
Correct Answer: D
Rationale: Ranitidine is not associated with an increased risk of osteoporosis in adults. It is a histamine-2 blocker commonly used to reduce stomach acid production and treat conditions such as ulcers and gastroesophageal reflux disease. On the other hand, the other options listed are known to increase the risk of osteoporosis:
Phaeochromocytoma is not associated with:
- A. Weight gain
- B. Fear of death (angor animi)
- C. Paroxysmal hypertension
- D. Constipation
Correct Answer: A
Rationale: Phaeochromocytoma is a rare neuroendocrine tumor that usually originates from the adrenal glands and produces excess catecholamines. The characteristic symptoms of phaeochromocytoma include paroxysmal (sudden and severe) hypertension, fear of impending death (angor animi), and episodic symptoms like palpitations, headache, and diaphoresis. However, weight gain is not a typical manifestation associated with phaeochromocytoma. In fact, patients with this condition may experience unintentional weight loss due to the effects of excess catecholamines on metabolism and appetite suppression. Therefore, weight gain is not a significant feature observed in individuals with phaeochromocytoma.
Thyroid-stimulating hormone (TSH):
- A. is a glycoprotein hormone.
- B. is synthesized in the follicular cells of the thyroid gland.
- C. has gonadotropic activity.
- D. stimulates the activity of parafollicular thyroid cells.
Correct Answer: A
Rationale: Thyroid-stimulating hormone (TSH) is a glycoprotein hormone that is produced and secreted by the anterior pituitary gland. It acts on the thyroid gland to stimulate the production and release of thyroid hormones, T3 (triiodothyronine) and T4 (thyroxine). TSH plays a crucial role in regulating the function of the thyroid gland and maintaining overall thyroid hormone levels in the body.
Which of the following are common symptoms of hyperthyroidism?
- A. Tremor
- B. Weight gain
- C. Heat intolerance
- D. Diarrhoea
Correct Answer: A
Rationale: Tremor (A): Tremors or shaky hands are common symptoms of hyperthyroidism. This is due to the increased metabolic rate caused by excess thyroid hormone in the body.
Enlargement of the bones of the hands, feet, and face due to overproduction of growth hormone is called :
- A. Acromegaly
- B. Cushing syndrome
- C. Gigantism
- D. Myxedema
Correct Answer: A
Rationale: Acromegaly is the condition characterized by the enlargement of the bones of the hands, feet, and face due to the overproduction of growth hormone in adults. This excess growth hormone typically comes from a benign tumor in the pituitary gland, leading to the gradual enlargement of these body parts. Cushing syndrome, on the other hand, is caused by prolonged exposure to high levels of cortisol and is not directly related to bone enlargement. Gigantism is the condition of excessive growth in height due to overproduction of growth hormone occurring in children before the closure of growth plates. Myxedema is a term used to describe severe hypothyroidism and is not directly associated with bone enlargement.